(BPT) – If you’ve had hives, you know how challenging they can be. But you may not know that there is more than one type of hives, or urticaria, and that treatments are available. A brief episode of ...

Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of ...

The first oral BTK blocker for chronic spontaneous urticaria, Rhapsido offers a more convenient treatment option for patients who still show symptoms after antihistamine treatment.

Most people have experienced hives at some point -- those itchy, raised welts that flare up in response to something like ...

Chronic spontaneous urticaria (CSU) is more than a skin condition, it’s an often-misunderstood autoimmune disease that can ...

Dealing with six weeks or more of itchy, uncomfortable hives isn’t exactly a recipe for good mental health. Unfortunately, it’s the reality for people with chronic hives. Also known as chronic ...

The company believes its lead drug, which is currently in mid-stage testing, could address limitations of other therapies for ...

While allergies are the main cause of hives, stress can also contribute to the itchy red bumps that make up a rash. Here's ...